Correlation Between Biotechnology Ultrasector and Franklin Balance

Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Franklin Balance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Franklin Balance into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Franklin Balance Sheet, you can compare the effects of market volatilities on Biotechnology Ultrasector and Franklin Balance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Franklin Balance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Franklin Balance.

Diversification Opportunities for Biotechnology Ultrasector and Franklin Balance

0.27

Correlation Coefficient

Biotechnology Ultrasector  Franklin Balance

Modest diversification

The 3 months correlation between Biotechnology and Franklin is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Franklin Balance Sheet in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Balance Sheet and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Franklin Balance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Balance Sheet has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Franklin Balance go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Franklin Balance

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to under-perform the Franklin Balance. In addition to that, Biotechnology Ultrasector is 2.94 times more volatile than Franklin Balance Sheet. It trades about -0.13 of its total potential returns per unit of risk. Franklin Balance Sheet is currently generating about -0.33 per unit of volatility. If you would invest  3,883  in Franklin Balance Sheet on September 21, 2024 and sell it today you would lose (231.00) from holding Franklin Balance Sheet or give up 5.95% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Biotechnology Ultrasector Prof  vs.  Franklin Balance Sheet

Biotechnology Ultrasector

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Franklin Balance Sheet

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Balance Sheet has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Franklin Balance is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Biotechnology Ultrasector and Franklin Balance

The main advantage of trading using opposite Biotechnology Ultrasector and Franklin Balance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Franklin Balance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Balance will offset losses from the drop in Franklin Balance's long position.

The idea behind Biotechnology Ultrasector Profund and Franklin Balance Sheet pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.